[ad_1]
Ugur Shahin said that the antigen (antimicrobial) used for the Bioentech-Pfizer vaccine contained more than 1,260 amino acids. Of these amino acids, only nine have been converted to new steins, less than 1 percent. The vaccine tests all proteins and will work in the body to create multiple immunity. However, Corona doesn’t get a chance to take on the new Stein look very easily.
The EU Drug Control Administration (EMA) yesterday approved the use of the Bioentech-Pfizer vaccine in 28 EU countries. In this context, Ugur Shahin said, Emma’s registration process is quite long. Many countries, including the EU authorities, have had to answer many questions about their research and the quality of vaccines.
Ugur Shaheen’s Bioentech Company and Co-Founder and Medical Director Izlem Taresi have yet to receive the vaccine manufactured by their company. He said other researchers at the institute also did not receive the vaccine, adding that they would receive it when it came to the German government’s immunization program.
Despite strict lockdown rules in Germany, 19,526 people have been infected with the coronavirus in 24 hours from yesterday to Tuesday. At least 544 people have died in the Crown, according to the Robert Koch Institute for Infectious Disease Research in Germany.
